Verenium Corporation: Difference between revisions
No edit summary |
|||
| Line 3: | Line 3: | ||
Diversa recently announced a buyout of Celunol, a leading corporation developing enzymes for [[cellulosic ethanol]] production. Celunol has received substantial backing from venture capitalist [[Vinod Khosla]]. The buyout will be financed by $90 million of Diversa stock plus payment of Celunol debt; Vinod Khosla will become one of the joint corporations largest single shareholders.<ref>"Sea of Dreams: Genetically Modified Microbes will lead to a Revolution in Industrial Biotechnology", an article on page eighty-one of the [[1 May]] [[2004]] issue of ''[[The Economist]]''</ref> |
Diversa recently announced a buyout of Celunol, a leading corporation developing enzymes for [[cellulosic ethanol]] production. Celunol has received substantial backing from venture capitalist [[Vinod Khosla]]. The buyout will be financed by $90 million of Diversa stock plus payment of Celunol debt; Vinod Khosla will become one of the joint corporations largest single shareholders.<ref>"Sea of Dreams: Genetically Modified Microbes will lead to a Revolution in Industrial Biotechnology", an article on page eighty-one of the [[1 May]] [[2004]] issue of ''[[The Economist]]''</ref> |
||
After Diversa's merger with Celunol the new company is now called, [[Verenium]]. The name Diversa is no longer used. |
|||
==People at Diversa== |
==People at Diversa== |
||
Revision as of 07:36, 22 June 2007
Diversa (DVSA)[1] is a San Diego, California-based company that specializes in bio-fuel, industrial biotechnology and metagenomics. According to the Economist article listed in the "References" section, Diversa prospects in hot springs, ocean beds, soda lakes, and on the Arctic tundra for genes potentially useful in industry.
Diversa recently announced a buyout of Celunol, a leading corporation developing enzymes for cellulosic ethanol production. Celunol has received substantial backing from venture capitalist Vinod Khosla. The buyout will be financed by $90 million of Diversa stock plus payment of Celunol debt; Vinod Khosla will become one of the joint corporations largest single shareholders.[2]
After Diversa's merger with Celunol the new company is now called, Verenium. The name Diversa is no longer used.
People at Diversa
- Edward T. Shonsey (CEO, as of October 6, 2005)
External link
References
- ^ http://finance.yahoo.com/q?s=dvsa
- ^ "Sea of Dreams: Genetically Modified Microbes will lead to a Revolution in Industrial Biotechnology", an article on page eighty-one of the 1 May 2004 issue of The Economist